|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.37 USD | +0.10% |
|
+0.26% | +34.40% |
| 05-22 | CVC, GBL launch EUR10.7 billion bid for Italian drugmaker Recordati | RE |
| 05-11 | Catalyst Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise | MT |
| Market Cap | 3.84B 3.33B 3.07B 2.88B 5.38B 368B 5.49B 36.63B 14.18B 177B 14.41B 14.1B 616B | P/E Ratio 2026 * |
16.5x | P/E Ratio 2027 * | 13.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.84B 3.33B 3.07B 2.88B 5.38B 368B 5.49B 36.63B 14.18B 177B 14.41B 14.1B 616B | EV / Sales 2026 * |
6.07x | EV / Sales 2027 * | 5.38x |
| Free-Float |
94.43% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Catalyst Pharmaceuticals, Inc.
| 1 day | +0.10% | ||
| 1 week | +0.26% | ||
| Current month | +0.45% | ||
| 1 month | +0.71% | ||
| 3 months | +28.54% | ||
| 6 months | +36.75% | ||
| Current year | +34.40% |
| 1 week | 31.28 | 31.39 | |
| 1 month | 31.13 | 31.39 | |
| Current year | 22.13 | 32.56 | |
| 1 year | 19.05 | 32.56 | |
| 3 years | 11.48 | 32.56 | |
| 5 years | 4.81 | 32.56 | |
| 10 years | 0.63 | 32.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Daly
CEO | Chief Executive Officer | 65 | 2023-12-31 |
Michael Kalb
DFI | Director of Finance/CFO | 55 | 2023-12-31 |
Brian Elsbernd
CMP | Compliance Officer | 62 | 2016-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick McEnany
CHM | Chairman | 78 | 2001-12-31 |
David Tierney
BRD | Director/Board Member | 62 | 2002-09-30 |
Richard Daly
BRD | Director/Board Member | 65 | 2015-02-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-02 | Fiscal year | Chief Technology Officer | 3,795 | 0.0031% | ||
| 02-16 | Fiscal year | Head of Human Resources | 1,585 | 0.0013% | ||
| 01-04 | Fiscal year | Chief Financial Officer | 16,358 | 0.0133% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.10% | +0.26% | +23.46% | +169.97% | 3.84B | ||
| +1.63% | -2.74% | +17.91% | -18.09% | 62.21B | ||
| +2.50% | +4.43% | +64.44% | +216.37% | 59.45B | ||
| -0.92% | +28.60% | +28.60% | +28.60% | 38.9B | ||
| +0.26% | +9.80% | -55.40% | -65.15% | 36.4B | ||
| +2.94% | +1.79% | +50.28% | -35.26% | 29.52B | ||
| +2.32% | +6.51% | +56.62% | +76.65% | 21.54B | ||
| +7.94% | -3.78% | +78.88% | -59.73% | 19.7B | ||
| +4.52% | -0.26% | -5.39% | +112.81% | 16.18B | ||
| +0.78% | -1.57% | +44.59% | +98.01% | 15.89B | ||
| Average | +2.23% | +1.34% | +30.40% | +52.42% | 30.36B | |
| Weighted average by Cap. | +2.00% | +1.85% | +29.67% | +45.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 632M 548M 506M 474M 885M 60.51B 904M 6.03B 2.33B 29.17B 2.37B 2.32B 101B | 713M 619M 570M 534M 999M 68.28B 1.02B 6.8B 2.63B 32.91B 2.68B 2.62B 114B |
| Net income | 238M 207M 190M 178M 333M 22.8B 340M 2.27B 880M 10.99B 894M 875M 38.21B | 291M 253M 233M 218M 407M 27.86B 416M 2.78B 1.07B 13.43B 1.09B 1.07B 46.7B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 31.37 $ | +0.10% | 1,020,948 |
| 26-06-10 | 31.34 $ | 0.00% | 960,794 |
| 26-06-09 | 31.34 $ | +0.19% | 1,350,260 |
| 26-06-08 | 31.28 $ | +0.03% | 1,589,018 |
| 26-06-05 | 31.27 $ | -0.06% | 1,534,843 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CPRX Stock
Select your edition
All financial news and data tailored to specific country editions

















